The ROE as of November 2024 (TTM) for Absci Corporation (ABSI) is -46.56%

According to Absci Corporation’s latest financial reports and current stock price. The company's current ROE is -46.56%. This represents a change of 293.73% compared to the average of -11.82% of the last 4 quarters.

Absci Corporation (ABSI) Historical ROE (quarterly & annually)

How has ABSI ROE performed in the past?

The mean historical ROE of Absci Corporation over the last ten years is -19.15%. The current -46.56% ROE has changed 143.13% with respect to the historical average. Over the past ten years (40 quarters), ABSI's ROE was at its highest in in the March 2021 quarter at 11.13%. The ROE was at its lowest in in the June 2021 quarter at -111.00%.

Absci Corporation (ABSI) ROE by Quarter and Year

Discovering the peaks and valleys of Absci Corporation ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Absci Corporation (ABSI) Average ROE

How has ABSI ROE performed in the past?

The current ROE of Absci Corporation (ABSI) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Absci Corporation (ABSI) ROE vs. Peers

How is ABSI’s ROE compared to its peers?

Absci Corporation’s ROE is greater than Recursion Pharmaceuticals, Inc. (-76.53%), greater than Affimed N.V. (-193.85%), greater than Sana Biotechnology, Inc. (-94.47%), greater than Relay Therapeutics, Inc. (-45.75%), greater than Exscientia plc (-52.50%), greater than VectivBio Holding AG (-56.92%), greater than Zura Bio Limited (-39.61%), greater than Elevation Oncology, Inc. (-59.73%), greater than Icosavax, Inc. (-20.22%), less than AVROBIO, Inc. (29.68%), greater than Hepion Pharmaceuticals, Inc. (-505.74%), less than Precision BioSciences, Inc. (17.63%), greater than Caribou Biosciences, Inc. (-45.46%), less than ContraFect Corporation (376.50%), greater than Graphite Bio, Inc. (-57.96%), greater than Day One Biopharmaceuticals, Inc. (-22.40%), greater than Acumen Pharmaceuticals, Inc. (-32.99%), greater than X4 Pharmaceuticals, Inc. (-32.51%), greater than Inozyme Pharma, Inc. (-88.42%),

Build a custom stock screener for Absci Corporation (ABSI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Absci Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Absci Corporation (ABSI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Absci Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.